Ross Haghighat is Director of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 124,546 shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on May 26, 2023, when has been sold 3,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
0% 3M change
0% 12M change
Total Value Held $0

Ross Haghighat Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 26 2023
BUY
Exercise of conversion of derivative security
-
3,300 Added 2.58%
124,546 Common Stock
RH

Ross Haghighat

Director
Seattle, WA

Track Institutional and Insider Activities on KDNY

Follow CHINOOK THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KDNY shares.

Notify only if

Insider Trading

Get notified when an Chinook Therapeutics, Inc. insider buys or sells KDNY shares.

Notify only if

News

Receive news related to CHINOOK THERAPEUTICS, INC.

Track Activities on KDNY